Sd Biosensor Inc. (137310)

Overview

SD Biosensor, Inc is a pioneering in-vitro diagnostic company that plays a significant role both in South Korea and on the international stage by offering comprehensive point-of-care diagnostic solutions. Founded in 2010 with its headquarters located in Suwon, South Korea, the company has made notable strides in the field of diagnostics, focusing on ease of use, accessibility, and contributing to swift clinical decision-making processes. Through its extensive research and development, SD Biosensor, Inc strives to meet the evolving needs of healthcare systems worldwide by providing innovative diagnostic products and services.

Products and Services

STANDARD Q: This product line includes a variety of rapid test parameters, notably for COVID-19, among other diagnostic tests. STANDARD Q is tailored to provide quick and reliable diagnostic solutions for a range of infectious diseases, facilitating timely and effective patient care.

STANDARD F: This represents a multi-parametric and random accessible FIA (Fluorescence Immunoassay) system, designed to deliver diagnostic results efficiently to laboratories. STANDARD F integrates seamlessly into clinical settings to support healthcare professionals by providing accurate diagnostic information rapidly.

STANDARD E: Focused on mass screening tests, STANDARD E employs enzyme-linked immunosorbent assay (ELISA) technology. This product is crucial for extensive screening programs, offering high-throughput and highly sensitive diagnostic results, critical for managing and controlling the spread of various infectious diseases.

STANDARD M: A comprehensive point-of-care MDx (Molecular Diagnostics) system, STANDARD M is engineered for clinical decision-making near the patient. It encompasses analyzers, assay menus, qPCR reagents, and NA (Nucleic Acid) extraction kits, embodying the next generation of diagnostics by providing swift and accurate results directly at the point of care.

procell Dx: Specialized in vitro diagnostic products directed at the diagnosis of infectious diseases, like tuberculosis and SARS-CoV-2, and for monitoring the immune status of individuals through the interferon gamma release assay. This range underscores the company's commitment to tackling global infectious disease challenges through advanced diagnostic technologies.

Blood Glucose Meters: Catering to the growing need for self-monitoring of blood glucose levels, SD Biosensor, Inc offers user-friendly blood glucose meters. These devices are critical for individuals managing diabetes, enabling them to maintain control over their condition with ease and precision.